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1. Introduction
Prostaglandins are a family of biologically lipid acids synthe-
sized by cyclooxygenase from a common precursor, arachidonic
acid. Previous studies have indicated that prostaglandin E1 (PGE1)
and PGE2, and other prostanoids, inﬂuence adrenergic neurotrans-
mission in the vas deferens from several species [1–4]. In human
vas deferens, the motor innervation is mainly noradrenergic [5,6]
and PGE1 and PGE2 have been reported to inhibit neurogenic
contractions by decreasing the release of norepinephrine from
sympathetic nerve endings [7]. The mechanisms whereby PGE1
and PGE2 modify neurotransmitter release have received much
attention but remain poorly understood. Prostaglandins of the E
series inhibit transmitter release by an action on stimulus-
secretion coupling and more speciﬁcally on the availability of
Ca2+ for the release mechanism [8].
K+ channels modulate the adrenergic contractile responses in
human vas deferens [9] and several agents have been shown to
inhibit neurotransmitter release from nerve endings through a
mechanism that involves the opening of prejunctional K+ channels,
membrane hyperpolarization and reduction in Ca2+ inﬂux via
voltage-activated Ca2+ channels [10,11]. In vas deferens, it has been
demonstrated that K+ channels are involved in the prejunctional
inhibitory effects of atrial natriuretic factor [12], a2-adrenoceptor
agonists [13] andsildenaﬁl, an inhibitor ofphosphodiesterase5 [14].
Activation of K+ channels stimulates cellular K+ efﬂux [15]. In
vascular smooth muscle, it has been demonstrated that an
increased extracellular K+ concentration ([K+]o) evokes rapid
hyperpolarization and relaxation [16] by stimulating an oua-
bain-sensitive Na+,K+-ATPase [17]. In rat vas deferens, increased
extracellular K+ concentrations lower than those necessary to
induce contraction of the smooth muscle inhibit electrically
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A B S T R A C T
We studied the role of K+ channels and Na+,K+-ATPase in the presynaptic inhibitory effects of
prostaglandin E1 (PGE1) and PGE2 on the adrenergic responses of human vas deferens. Furthermore, we
determined the effects of increasing extracellular K+ concentrations ([K+]o) and inhibition of Na
+,K+-
ATPase on neurogenic and norepinephrine-induced contractile responses. Ring segments of the
epididymal part of the vas deferens were taken from 45 elective vasectomies and mounted in organ
baths for isometric recording of tension. The neuromodulatory effects of PGEs were tested in the
presence of K+ channel blockers. PGE1 and PGE2 (10
8 to 106 M) induced inhibition of adrenergic
contractions. The presence of tetraethylammonium (103 M), charybdotoxin (107 M), or iberiotoxin
(107 M), prevented the inhibitory effects of PGE1 and PGE2 on the adrenergic contraction. Both
glibenclamide (105 M) and apamin (106 M) failed to antagonize PGE1 and PGE2 effects. Raising the
[K+]o from 15.8 mM to 25.8 mM caused inhibition of the neurogenic contractions. Ouabain at a
concentration insufﬁcient to alter the resting tension (106 M) increased contractions induced by
electrical stimulation but did not alter the contractions to norepinephrine. The inhibition of neurogenic
responses induced PGE1, PGE2 and increased extracellular concentration of K
+ was almost completely
prevented by ouabain (106 M). The results demonstrate that PGE1 and PGE2 inhibit adrenergic
responses by a prejunctional mechanism that involves the activation of large-conductance Ca2+-
activated K+ channels and Na+,K+-ATPase.
 2011 Elsevier Inc. All rights reserved.
* Corresponding author at: Departamento de Fisiologı´a, Facultad de Medicina y
Odontologı´a, Av. Blasco Iba´n˜ez, 15, 46010 Valencia, Spain. Tel.: +34 963864644;
fax: +34 963864642.
E-mail address: Pascual.Medina@uv.es (P. Medina).
Contents lists available at ScienceDirect
Biochemical Pharmacology
journal homepage: www.e lsev ier .com/ locate /b iochempharm
0006-2952/$ – see front matter  2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.bcp.2011.03.021
Author's personal copy
induced contractions [18]. A role for increased [K+]o and Na
+,K+-
ATPase inmodulation of adrenergic neurotransmission in the human
vas deferens has not yet been investigated. Therefore, the present
study was designed to examine the effects of increasing [K+]o and
Na+,K+-ATPaseonadrenergic contractions of humanvasdeferens and
the contribution of K+ channels and Na+,K+-ATPase to the inhibitory
effects of PGE1 and PGE2 on adrenergic neurotransmission.
2. Material and methods
Segments (15–20 mm long) of the epididymal part of the vas
deferens were taken from 45 healthy men without previous history
of psychiatric or physical illness,medication use, or substance abuse
(mean age, 39, range 30–44 years) who were sterilized by elective
vasectomy. The study was approved by the Human Ethics
Committee of our institution and informed consent was obtained
from each subject before the study. The specimens were placed in
chilled isotonic NaCl, and were divided into ring preparations 3–
4 mm long.
2.1. Isolated vas deferens preparation
Ring preparations were suspended between two L-shaped
stainless steel pins. One pin was ﬁxed to the organ bath wall while
the other was connected to a strain gauge (Grass FT03, Grass
Instruments Division Astromed, Inc., West Warwick, RI, USA).
Changes in isometric force were recorded by use of Chart v3.4/s
software and aMacLab/8e data acquisition system (ADInstruments,
East Sussex, UK). Each preparation was set up in a 4-ml bath
containing modiﬁed Krebs–Henseleit solution of the following
millimolar composition: NaCl, 115; KCl, 4.6; KH2PO4 1.2;
MgCl26H2O, 1.2; CaCl2, 2.5; NaHCO3, 25; glucose, 11.1; and
disodium EDTA, 0.01. The solution was equilibrated with 95% O2
and5%CO2. Thepreparationswereallowed toequilibrate for1-hand
during this time tension was adjusted to a ﬁnal tension of 19.6 mN.
Electrical ﬁeld stimulation was provided by a Grass S88
stimulator (Grass Instruments Division Astromed, Inc., West
Warwick, RI, USA) via two platinum electrodes positioned on
each side and parallel to the axis of the ring. Single square wave
pulses (0.25 ms pulse duration, 20 Hz, at a supramaximal voltage
of 20 V cm1) were used. The train duration was 5 s and the
stimulation interval 180 s. The stimulation parameters used elicit
contractile responses that are abolished by tetrodotoxin (106 M)
or prazosin (106 M) [19].
2.2. Experimental procedure
To study the neuromodulatory action of prostaglandins, when
electrically induced phasic contractions were stable (after 15–
20 min), PGE1 or PGE2 (10
8 to 106 M) were added cumulatively
to the preparations and the effects of electrical ﬁeld stimulation
were recorded. To examine the role of K+ channel activation in the
effects of PGE1 and PGE2 on electrical ﬁeld stimulation induced
contractions, concentration–response curves to PGE1 and PGE2
were established in the presence of one of the following inhibitors:
TEA (103 M), a nonspeciﬁc K+ channel blocker [20], glibenclamide
(105 M), a selective blocker of ATP-sensitive K+ (KATP) channels
[21], charybdotoxin (107 M), an inhibitor of Ca2+-activated K+
(KCa) channels of both large-conductance (KCa1.1) [22] and
intermediate-conductance (KCa3.1) [23], iberiotoxin (10
7 M), an
inhibitor of KCa1.1 channels [24], or apamin (10
6 M), an inhibitor
of KCa of small-conductance (KCa2) channels [25].
Concentration–response curves to norepinephrine were
obtained in a cumulative manner in the absence (control) and in
the presence of PGE1 (10
6 M) or PGE2 (10
6 M) from separate
preparations.
K+ channels activation stimulates K+ efﬂux [15]. As increases in
the [K+]o evoke rapid vascular smooth muscle relaxation and
hyperpolarization [16], we studied the adrenergic responses in the
presence of increased [K+]o (10.8–25.8 mM) to check the possibility
that increasing [K+]o may inhibit adrenergic contractions. At the
end of each series, the physiological concentration of K+ was
restored by washing out with Krebs–Henseleit solution and
electrical stimulation was repeated to conﬁrm the reversibility
of the effects of high K+ concentrations on neurogenic response.
To determine whether Na+,K+-ATPase activity is involved in the
adrenergic responses of the human vas deferens, the contractions
to electrical ﬁeld stimulation and norepinephrine were recorded
before and 15 min after the addition of ouabain (107 to 106 M), a
Na+,K+-ATPase inhibitor.
In another group of experiments, the inﬂuence of Na+,K+-ATPase
on the PGE1-, PGE2- or increasing K
+ concentrations-induced
inhibition of contractions evoked by electrical ﬁeld stimulation
was examined by exposing vas deferens rings to ouabain (106 M)
for 15 min before the addition of PGE1 (10
8 to 3  106 M), PGE2
(108 to 3  106 M) or [K+]o (10.8–25.8 mM) and the responses to
electrical stimulation were recorded.
2.3. Drugs
The following drugs were used: norepinephrine hydrochloride,
prazosin hydrochloride, tetrodotoxin, prostaglandin E1 (PGE1),
prostaglandin E2 (PGE2), tetraethylammonium bromide (TEA),
charybdotoxin, iberiotoxin, apamin, glibenclamide and ouabain
(Sigma Chemical Co., St. Louis, MO, USA). All drugs were dissolved
in Krebs solution, except for glibenclamide and ouabain which
were dissolved initially in dimethyl sulphoxide and further diluted
in Krebs solution to the proper ﬁnal concentration. Stock solutions
of the drugs were freshly prepared every day, and kept on ice
throughout the experiment.
2.4. Data analysis
All values are expressed as means  S.E.M. Contractions are
reported as absolute values (mN) or as percentages of control
responses. pD2 values (negative logarithm of themolar concentration
at which half-maximum contraction occurs) were determined from
individual concentration–response curves by non-linear regression
analysis. The responses obtained in each subject were averaged to
yield a single value. Differences between untreated and treated
groups were assessed by one-way analysis of variance (ANOVA), and
then Bonferroni’s test was performed. Statistical signiﬁcance was
accepted at P < 0.05.
3. Results
Electrical ﬁeld stimulation (EFS) induced phasic contraction in
segments of the vas deferens which was abolished by tetrodotoxin
(106 M) and prazosin (106 M), thus indicating that the smooth
muscle contraction was due to the release of norepinephrine from
adrenergic nerves acting on a1 adrenoceptors (results not shown).
Fig. 1A shows representative tracings of the effects of PGE1
(108 to 106 M) on EFS-evoked contractions of the vas deferens
rings in the absence (control) and in the presence of K+ channel
blockers and Fig. 1B and C summarizes the results from all the
experiments. PGE1 induced concentration-dependent inhibition of
EFS-evoked contractions with a pD2 value of 7.35  0.10 (Fig. 1B
and C). Apamin (106 M) and glibenclamide (105 M) did not modify
the inhibitory effect of PGE1 on neurogenic contractions whereas
charybdotoxin (107 M), TEA (103 M) and iberiotoxin (107 M)
reduced signiﬁcantly the inhibitory effects of PGE1. The effects of PGE2
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on neurogenic contractions and the inhibition of these effects by K+
channel blockers were similar to those observed with PGE1 (Fig. 2).
Fig. 3A and B shows that the increase in [K+]o in the Krebs–
Henseleit solution caused concentration-dependent inhibition of
the EFS-induced contractions with a maximum inhibitory effect of
96%. The inhibition was reversible after washout of the excess of K+.
Ouabain (107 to 106 M) had no signiﬁcant effect on the basal
tone of the preparations but increased contractile responses to EFS
(Fig. 3C and D). Ouabain (106 M) counteracted the inhibitory
effects of PGE1, PGE2 and increasing [K
+]o on EFS-induced
contractions (Fig. 4).
Cumulative addition of norepinephrine (106 to 3  104 M)
induced repetitive phasic, concentration-dependent contractions
with a pD2 value of 5.01  0.10. Pretreatment with PGE1 (106 M) or
PGE2 (10
6 M) did not affect the contractions induced by norepi-
nephrine (Table 1). Moreover, pretreatment with either ouabain
(106 M) or increasing [K+]o to 25.8 mM were without effect on
norepinephrine-induced contractions (Fig. 5 and Table 1).
4. Discussion
The present study demonstrates a role for K+ channels and
Na+,K+-ATPase in the prejunctional inhibitory effects of PGE1 and
PGE2 on adrenergic responses of human vas deferens. It has been
demonstrated that PGE1 and PGE2 selectively depress neurogenic
contractions in human vas deferens without modifying the
contractions to norepinephrine [7]. The lack of effect of PGE1
and PGE2 on norepinephrine-induced contractions suggests that
postjunctional inhibitory mechanisms are not involved in the
neuromodulatory action of these prostaglandins. The inhibitory
effect on neurogenic contractions has been attributed to decreased
norepinephrine release from nerve endings in the human vas
deferens [7].
The mechanisms whereby PGE1 and PGE2 induce inhibition of
neurotransmitter release remain poorly understood. Several
agents could inhibit neurotransmitter release from nerve endings
in vas deferens through amechanism that involves activation of K+
channels. In human vas deferens, charybdotoxin-sensitive, iber-
iotoxin-insensitive, K+ channels modulate the adrenergic contrac-
Fig. 1. (A) Representative tracings showing the inhibitory effect of prostaglandin E1 on electrical ﬁeld stimulation (EFS)-evoked contractions of human vas deferens rings in
the absence and in the presence of K+ channel blockers. (B) and (C) summarize the results fromall the experiments. Resultswere calculated as the percentage of the contractile
response elicited by EFS (0.25 ms pulse duration, 20 Hz, at a supramaximal voltage of 20 V cm1, train duration 5 s) before the addition of prostaglandin E1. Values are
presented as the mean  S.E.M. Numbers in parentheses are the number of subjects in each group.
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Fig. 2. Graphical representation of the inhibition of EFS-induced contractions by
increasing concentrations of prostaglandin E2 in the absence (control) and in the
presence of K+ channel blockers. Results were calculated as the percentage of the
contractile response elicited by EFS before the addition of prostaglandin E2. Values
are presented as the mean  S.E.M. Numbers in parentheses are the number of
subjects in each group.
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tile response by interfering with Ca2+ entry through dihydropyr-
idine Ca2+ channels [9]. Furthermore, it has been shown that K+
channels are involved in the prejunctional inhibitory effects of
atrial natriuretic factor in the rabbit isolated vas deferens [12] and
in the a2-adrenoceptor-mediated inhibition in rat vas deferens
[13]. In the human vas deferens, sildenaﬁl, an inhibitor of
phosphodiesterase 5, inhibits adrenergic contractions through
activation of presynaptic KCa1.1 channels [14].
Glibenclamide has been shown to block KATP channels [21] with
an IC50 in the micromolar range for smooth muscle preparations
[26]. In rat vas deferens, the inhibitory action of calcitonin-gene-
related peptide (CGRP) on neurotransmission was at least in part
mediated by the activation of KATP channels in sympathetic nerve
terminals as shown by the prevention of the neuromodulatory
effects of CGRP in the presence of glibenclamide 105 M [27]. Our
results in human vas deferens demonstrate that glibenclamide at
concentration as high as 105 M did not modify the inhibition
induced by PGEs on adrenergic responses. These results rule out the
involvement of KATP channels activation in the inhibitory effects of
PGEs on neurogenic contractions of the human vas deferens.
On the other hand, we tested the effects of TEA, a nonspeciﬁc K+
channel blocker [20] on the neuromodulatory effects of PGE1 and
PGE2. It is accepted that blockade with 10
3 M TEA is sufﬁcient to
almost fully inhibit KCa1.1 channels [28]. In our experiments
millimolar concentrations of TEA prevented the inhibitory effects
of PGE1 and PGE2 on neurogenic contractions, suggesting a role of
KCa channels in this effect.
To further characterize the member of KCa channel group
involved in the neuromodulatory effects of PGEs we used more
selective blockers of KCa channels. Apamin has proved to be
extremely valuable as a highly speciﬁc blocker for which the only
known receptors are the KCa channels of small conductance (KCa2)
[29]. In our experiments, apamin 106 M, a concentration expected
to block completely all subtypes of KCa2 channels, failed to alter the
Fig. 3. (A) Representative tracing and (B) bar graph showing the inhibitory effects of increasing extracellular K+ concentration ([K+]o) from 5.8 to 25.8 mM on electrical ﬁeld
stimulation (EFS)-induced contractions. After wash out (W) with fresh Krebs–Henseleit solution ([K+]o = 5.8 mM), the mean amplitude of contractions induced by EFS was
reverted to initial conditions. (C) Representative tracing and (D) bar graph showing the contractile responses to EFS in the absence (control) and in the presence of ouabain
(107 to 106 M). Results in (B) and (D) were calculated as the percentage of the contractile response elicited by EFS before the addition of K+ or ouabain. Values are
mean  S.E.M. Numbers in parentheses are the number of subjects in each group. *P < 0.05 versus control.
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Fig. 4. Inhibition of electrical ﬁeld stimulation (EFS)-induced contractions by prostaglandin E1 (PGE1), prostaglandin E2 (PGE2) and increasing extracellular K
+ concentration
([K+]o) from10.8 to 25.8 mM in the absence (control) and in the presence of ouabain (10
6 M). Results were calculated as the percentage of the contractile response elicited by
EFS before the addition of PGE1, PGE2 or K
+. Values are mean  S.E.M. Numbers in parentheses are the number of subjects in each group.
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inhibition caused by PGE1 and PGE2 on neurogenic contractions in
human vas deferens. These data indicate that KCa2 channels are not
involved in the neuromodulatory effects of PGE1 and PGE2.
Charybdotoxin, a blocker of both KCa1.1 and KCa3.1 channels
[22,23], prevented the inhibitory effects of PGE1 and PGE2 on
sympathetic contractions of the human vas deferens. These results
demonstrate that the K+ channels involved are sensitive to
charybdotoxin. Therefore, we tested the effect of iberiotoxin, a
selective blocker of KCa1.1 channels [24], on the effects of PGE1 and
PGE2 on adrenergic contractions. The marked effect of iberiotoxin
in the present study provides evidence for KCa1.1 channels as a
signiﬁcant component of PGE1 and PGE2 inhibitory effects on
neurogenic contractions of the human vas deferens.
A previous study in rat vas deferens demonstrated that
increasing [K+]o, at concentrations lower than those necessary to
induce contraction of the smoothmuscle, completely inhibited the
electrically induced contractions [18], an effect attributed to a
desensitization of the rat vas deferens to electrically induced
contractions. Studies of vascular smooth muscle showed that
increased [K+]o in the range 6–16 mM produce hyperpolarization
and vasodilatation by stimulating an ouabain-sensitive Na+,K+-
ATPase [17]. In guinea-pig vas deferens relatively high concentra-
tions of ouabain, an inhibitor of Na+,K+-ATPase, is reported to cause
a gradual increase in the norepinephrine release from the
peripheral adrenergic neurons [30] and an increase in the
sensitivity to norepinephrine [31]. Particularly for the vas deferens,
species is thought to play an important role in Na+,K+-ATPase
activity and function [31]. However, the effects of inhibition of
Na+,K+-ATPase on adrenergic responses of human vas deferens
have not been investigated. As the resting tension of human vas
deferens was not changed by ouabain in our experiments, we
suggest that Na+,K+-ATPase is not normally active in the relaxed
vas deferens smooth muscle. Furthermore, ouabain had no effect
on norepinephrine-mediated contractions at concentration of
106 M, but increased neurogenic contractions. These results
indicate that the enhanced neurogenic contractions induced by
ouabain involves the inhibition of Na+,K+-ATPase activity of the
adrenergic nerve endings.
Increasing [K+]o over the range that inhibits electrical ﬁeld
stimulation-induced adrenergic contractions should also stimulate
the Na+,K+-ATPase by increasing the amount of extracellular K+
that binds to the pump [32]. In human vas deferens, ouabain blocks
K+-induced inhibition of adrenergic contractions, indicating that
increasing [K+]o stimulates the Na
+,K+-ATPase in the range that
inhibits adrenergic contractions. Because Na+,K+-ATPase activity is
ultimately responsible formost of the restingmembrane potential,
the ability of increased extracellular K+ to regulate adrenergic
contractions could in part be due to its effect on Na+,K+-ATPase
activity. There are two effects of the pump onmembrane potential:
(i) an electrogenic effect, due to the 3Na+/2K+ exchange (this is the
Table 1
pD2 values and maximal contractions elicited by norepinephrine alone (control)
and in the presence of prostaglandin E1 (PGE1), PGE2, ouabain or increased
extracellular K+ concentration ([K+]o).
Norepinephrine pD2 S.E.M. Maximum contraction
(mN S.E.M.)
Control (n=7) 5.01 0.10 49.77.9
PGE1 (10
6M) (n=5) 5.11 0.09 48.65.3
PGE2 (10
6M) (n=5) 5.02 0.09 47.57.4
Ouabain (106M) (n=5) 4.95 0.14 49.58.3
[K+]o =25.8mM (n=5) 5.07 0.10 47.99.1
Values are means S.E.M. n, number of subjects.
Fig. 5. (A) Recordings illustrating the contractile effects of norepinephrine in the absence (control, extracellular K+ concentration [K+]o = 5.8 mM) and in the presence of [K
+]o
of 25.8 mM or ouabain (106 M). Concentration–response curves for norepinephrine in the absence (control, [K+]o = 5.8 mM) and in the presence of (B) [K
+]o of 25.8 mM, and
(C) in the presence of ouabain (106 M). Values are mean  S.E.M. Numbers in parentheses are the number of subjects in each group. *P < 0.05 versus control.
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smaller, but more rapid effect) and (ii) by maintaining the
transmembrane K+ gradient the membrane potential is created
(this is the more powerful, but slower effect). Our results suggest
that in the inhibitory effects of K+ on the adrenergic contractions of
human vas deferens only the ﬁrst effect is relevant because in our
experimental conditions it is not possible to increase the
transmembrane K+ gradient by increasing [K+]o.
However, involvement of other mechanisms/pathways cannot
be excluded. Recently, it has been demonstrated the proximity and
functional interaction between the KCa1.1 channel and Na
+,K+-
ATPase [33]. This interplay is suggested to depend on the proper
microenvironment. Previous studies demonstrated that inhibition
of Na+,K+-ATPase and subsequent accumulation of intracellular Na+
decreases KCa1.1 current [33,34]. Another possibility is that
inhibition of Na+,K+-ATPase by ouabain leads to an accumulation
of Na+ close to themicrodomains harboring KCa1.1 channels, which
inhibits the channel function.
Furthermore, ouabain blocked the inhibitory effects of PGE1 and
PGE2 on sympathetic contractions in human vas deferens,
suggesting that activation of Na+,K+-ATPase plays an important
role in the presynaptic inhibition of the norepinephrine release
induced by these prostaglandins. Consistent with our data, an
acute stimulatory effect of PGE1 and PGE2 on Na
+,K+-ATPase
activity was observed in rabbit renal proximal tubule cells and
cortical collecting tubule of the nephron [35,36].
In rat vas deferens it has been demonstrated that PGE2 is
released from the epithelium in response to ATP stimulation and it
is responsible for mediating the membrane hyperpolarization and
inhibition of contraction of smooth muscle cells by activating
cAMP-dependent K+ channels [37]. However, our results show that
PGE2 inhibited neurogenic contractions but did not exert
inhibitory effects on norepinephrine-induced contractions, indi-
cating that PGE2 acts directly on sympathetic nerve endings.
An important function of the vas deferens is the transport of
spermatozoa from the epididymis for inclusion in the semen. Since
a1-adrenoceptors activation by norepinephrine is required for
normal contraction of the vas deferens and consequent sperm
ejaculation [38], it seems likely that increased formation of PGE2 in
physiological and pathological conditions such as inﬂammation
[39], may cause aperistalsis of the adrenergically innervated vas
deferens by activating KCa1.1 channels and Na
+,K+-ATPase and
impairment of male fertility. Although the present studies provide
evidence that activation of presynaptic KCa1.1 channels inhibits
adrenergic contractions of vas deferens, future studies are necessary
to elucidate the potential therapeutic modiﬁcation of vas deferens
motility, via pharmacologic intervention of these channels.
The ﬁndings of the present study support the view that the
presynaptic inhibitory effect of PGE1 and PGE2 is mediated via
activation of large-conductance KCa channels. Increasing [K
+]o
induces reversible inhibition of adrenergic vas deferens contrac-
tions. These inhibitory effects on neurogenic contractions of
human vas deferens are mediated by activation of Na+,K+-ATPase.
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